Skip to main content
Help
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Lockups
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
Analysts
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia
· Delayed Price · Currency is AUD
Full Chart
Watchlist
Alerts
Compare
0.2420
-0.0430 (-15.09%)
Sep 11, 2026, 12:42 PM AEST
Overview
Financials
Forecast
Statistics
History
Profile
Chart
Financials
Income Statement
Balance Sheet
Cash Flow
Ratios
KPIs
Annual
Semi-Annual
TTM
ASX:PAR Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Mil
Millions
Data
Data Source
AUD
AUD
More
Download
Full Width
Fiscal Year
FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
Period Ending
Jun '26
Jun 30, 2026
Jun '25
Jun 30, 2025
Jun '24
Jun 30, 2024
Jun '23
Jun 30, 2023
Jun '22
Jun 30, 2022
Operating Revenue
-
-
-
-
0.08
Revenue
-
-
-
-
0.08
Revenue Growth
-
-
-
-
285.52%
Cost of Revenue
0.01
0.02
0.01
0.02
0.14
Gross Profit
-0.01
-0.02
-0.01
-0.02
-0.06
Selling, General & Admin
7.26
5.58
6.77
7.39
8.85
Research & Development
53.92
17.74
58.33
52.68
39.01
Operating Expenses
61.18
23.32
65.1
60.07
47.87
Operating Income
-61.19
-23.34
-65.11
-60.09
-47.93
Interest Expense
-2.46
-0.01
-0.01
-0.02
-0.03
Interest & Investment Income
0.42
0.36
0.41
1.4
0.05
Currency Exchange Gain (Loss)
-0.92
0.01
-0.05
-0.39
0.89
Other Non Operating Income (Expenses)
7.83
6.75
6.04
7.09
7.76
EBT Excluding Unusual Items
-56.33
-16.24
-58.73
-52
-39.25
Gain (Loss) on Sale of Assets
-0.01
-
-
-
-
Asset Writedown
-
-2.53
-
-
-
Other Unusual Items
-
-
-
0.09
-
Pretax Income
-56.33
-18.77
-58.73
-51.91
-39.25
Net Income
-56.33
-18.77
-58.73
-51.91
-39.25
Net Income to Common
-56.33
-18.77
-58.73
-51.91
-39.25
Net Income Growth
-
-
-
-
-
Shares Outstanding (Basic)
370
315
293
250
233
Shares Outstanding (Diluted)
370
315
293
250
233
Shares Change
17.66%
7.23%
17.43%
7.34%
1.21%
EPS (Basic)
-0.15
-0.06
-0.20
-0.21
-0.17
EPS (Diluted)
-0.15
-0.06
-0.20
-0.21
-0.17
EPS Growth
-
-
-
-
-
Additional Metrics
Mil
Millions
Data
Data Source
AUD
AUD
More
Download
Full Width
Fiscal Year
FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
Period Ending
Jun '26
Jun 30, 2026
Jun '25
Jun 30, 2025
Jun '24
Jun 30, 2024
Jun '23
Jun 30, 2023
Jun '22
Jun 30, 2022
Free Cash Flow
-43.69
-15.99
-65.94
-45.19
-32.21
Free Cash Flow Per Share
-0.12
-0.05
-0.23
-0.18
-0.14
Gross Margin
-
-
-
-
-81.45%
Operating Margin
-
-
-
-
-60498.78%
Profit Margin
-
-
-
-
-49542.54%
Free Cash Flow Margin
-
-
-
-
-40650.90%
EBITDA
-61.04
-23.19
-64.97
-59.93
-47.74
D&A For EBITDA
0.15
0.15
0.15
0.15
0.19
EBIT
-61.19
-23.34
-65.11
-60.09
-47.93